Phenotypic analysis of reconstituted lymphocyte populations
| Patient no. (days after transplantation) . | 1 (190) . | 5 (721) . | 6 (90) . | 7 (92) . | 8 (338) . | 9 (200) . | 10 (271) . | 12 (175) . | 13 (180) . | 17 (79) . |
|---|---|---|---|---|---|---|---|---|---|---|
| %CD3+CD4+ | 10.3 | 35.7 | 32.1 | 18.6 | 12.3 | 4.6 | 7.0 | 15.0 | 14.1 | 16.8 |
| %CD3+CD8+ | 24.4 | 10.4 | 17.1 | 48.9 | 63.4 | 16.0 | 27.5 | 43.6 | 27.5 | 46.5 |
| %CD19+ | 34.5 | 27.8 | 6.6 | 2.8 | 11.2 | 6.7 | 6.6 | 21.1 | 4.0 | 3.7 |
| %CD4+CD45RO+ | 66.8 | 74.8 | 63.9 | 76.2 | ND | 57.1 | ND | 76.6 | 77.9 | ND |
| %CD8+CD45RO+ | 85.9 | 48.6 | 36.2 | 44.8 | ND | 50.0 | ND | 38.4 | 64.2 | ND |
| %CD4+CD45RA+ | 33.2 | 22.9 | 39.9 | 23.8 | ND | 46.2 | ND | 30.5 | 37.6 | ND |
| %CD8+CD45RA+ | 17.3 | 50.8 | 74.1 | 52.9 | ND | 45.7 | ND | 76.2 | 35.8 | ND |
| Patient no. (days after transplantation) . | 1 (190) . | 5 (721) . | 6 (90) . | 7 (92) . | 8 (338) . | 9 (200) . | 10 (271) . | 12 (175) . | 13 (180) . | 17 (79) . |
|---|---|---|---|---|---|---|---|---|---|---|
| %CD3+CD4+ | 10.3 | 35.7 | 32.1 | 18.6 | 12.3 | 4.6 | 7.0 | 15.0 | 14.1 | 16.8 |
| %CD3+CD8+ | 24.4 | 10.4 | 17.1 | 48.9 | 63.4 | 16.0 | 27.5 | 43.6 | 27.5 | 46.5 |
| %CD19+ | 34.5 | 27.8 | 6.6 | 2.8 | 11.2 | 6.7 | 6.6 | 21.1 | 4.0 | 3.7 |
| %CD4+CD45RO+ | 66.8 | 74.8 | 63.9 | 76.2 | ND | 57.1 | ND | 76.6 | 77.9 | ND |
| %CD8+CD45RO+ | 85.9 | 48.6 | 36.2 | 44.8 | ND | 50.0 | ND | 38.4 | 64.2 | ND |
| %CD4+CD45RA+ | 33.2 | 22.9 | 39.9 | 23.8 | ND | 46.2 | ND | 30.5 | 37.6 | ND |
| %CD8+CD45RA+ | 17.3 | 50.8 | 74.1 | 52.9 | ND | 45.7 | ND | 76.2 | 35.8 | ND |
The data refer to percentages of total gated lymphocytes.
ND indicates not determined.